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TECHNICAL NOTE

Direct tumor visual feedback during free breathing in 0.35T
MRgRT
Taeho Kim1 | Benjamin C. Lewis1

| Alex Price1 | Thomas Mazur1 |

H. Michael Gach1,2 | Justin C. Park1 | Bin Cai1 | Erin Wittland1 | Lauren Henke1 |
Hyun Kim1 | Sasa Mutic1 | Olga Green1
1
Department of Radiation Oncology,
Washington University School of Medicine,
St Louis, MO, 63110, USA

Abstract
To present a tumor motion control system during free breathing using direct tumor

2
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visual feedback to patients in 0.35 T magnetic resonance‐guided radiotherapy
(MRgRT). We present direct tumor visualization to patients by projecting real‐time
cine MR images on an MR‐compatible display system inside a 0.35 T MRgRT bore.
The direct tumor visualization included anatomical images with a target contour and
an auto‐segmented gating contour. In addition, a beam‐status sign was added for
patient guidance. The feasibility was investigated with a six‐patient clinical evaluation of the system in terms of tumor motion range and beam‐on time. Seven
patients without visual guidance were used for comparison. Positions of the tumor
and the auto‐segmented gating contour from the cine MR images were used in
probability analysis to evaluate tumor motion control. In addition, beam‐on time was
recorded to assess the efﬁcacy of the visual feedback system. The direct tumor
visualization system was developed and implemented in our clinic. The target contour extended 3 mm outside of the gating contour for 33.6 ± 24.9% of the time
without visual guidance, and 37.2 ± 26.4% of the time with visual guidance. The
average maximum motion outside of the gating contour was 14.4 ± 11.1 mm without and 13.0 ± 7.9 mm with visual guidance. Beam‐on time as a percentage was
43.9 ± 15.3% without visual guidance, and 48.0 ± 21.2% with visual guidance, but
was not signiﬁcantly different (P = 0.34). We demonstrated the clinical feasibility
and potential beneﬁts of presenting direct tumor visual feedback to patients in
MRgRT. The visual feedback allows patients to visualize and attempt to minimize
tumor motion in free breathing. The proposed system and associated clinical workﬂow can be easily adapted for any type of MRgRT.
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1 | INTRODUCTION

ET AL.

associated with the splitter‐based approach: (a) the TDS display
depends on video signal of a splitter; (b) displaying the entire TDS

In previous studies, tumors in the thorax were shown to move up
to 5 cm

1

and rotate up to 45°

2

during respiration. Conventional

respiratory motion‐compensation techniques such as surrogate‐

screen to patients includes unnecessary information that may confuse the patient, thus requiring further processing for advanced
visual guidance.18

based respiratory gating, breath‐hold, and marker‐based tumor

In our study, we developed a visual guidance system which does

tracking3–5 are clinically useful for tumor motion management but

not impact the TDS display. In addition, a customizable visual guid-

signiﬁcant variations in cycle‐to‐cycle breathing can cause treat-

ance display was added without intensive programming that opti-

ment inaccuracies.6,7 Recently, several respiratory monitoring sys-

mizes the information provided to the patient for efﬁcient guidance.

tems3,7–10 were introduced for respiratory motion management in

Through the study, we implemented the visual guidance system in a

radiotherapy providing respiratory guidance during radiotherapy in

clinical workﬂow and investigated its impact on tumor motion con-

11,12

addition to medical imaging.

For instance, audio‐visual biofeed-

trol during free breathing in 0.35 T MRgRT.

back7 uses a noninvasive external marker to measure abdominal
motion and uses audio‐visual (AV) tools to return that information
to the patient for respiratory motion guidance. Audio‐visual
biofeedback can reduce average cycle‐to‐cycle variations in breathing displacement and period by up to 50% and 70%, respec-

2 | MATERIALS AND METHODS
2.A | 0.35T MR‐guided radiotherapy

tively.7,13 However, the applications of this system may be limited

A 0.35 T MRgRT MRIdian system (ViewRay Inc., Oakwood Village,

by an insufﬁcient correlation between tumor and surrogate

Ohio) with a linear accelerator radiation therapy delivery system

motion.6,14

was used in this study. In our institutional clinical workﬂow, volu-

Real‐time 2D tumor tracking in MR‐guided radiotherapy (MRgRT)

metric MRIs are acquired using steady‐state precession (TrueFISP)

became clinically available in 2014.15,16 MRgRT improves local con-

in an axial orientation to position patients and localize treatment

trol and spares critical organs by providing superior soft tissue con-

targets.16 After the clinical team had reviewed the MRIs, and veri-

trast resolution and real‐time imaging‐based delivery. However,

ﬁed the target contours and expected dose, 2D TrueFISP cine

irregular tumor motion still hinders treatment efﬁciency in gated

MRIs were acquired at 4 frames per second in a sagittal plane

radiotherapy. Visual guidance systems in MRgRT have been intro-

during

duced for improving tumor motion control in voluntary breath‐

0.35 × 0.35 cm2 with 5, 7, or 10 mm slice thicknesses, depending

hold.17,18 For example, Kim et al. displayed the treatment delivery

on the tracking efﬁciency. The tracking efﬁciency is related to the

system (TDS) operator screen inside the bore of the treatment sys-

shape, contrast, and image texture of targets. Cine MRIs were dis-

tem by using a video signal splitter and an MR‐compatible beam pro-

played on the TDS monitor in real time during radiation delivery,

jector. In a similar approach, de Koste et al. displayed the TDS on an

as shown in Fig. 1(d). The TDS display included cine MRIs and

MR‐compatible monitor by using a video signal splitter and an adjus-

beam delivery information. The system paused the cine MRI dis-

table mirror. The splitters supply the video signal of the TDS com-

play during gantry motion due to signiﬁcant moving metal‐related

puter to an in‐room display device. There are two challenges

MRI artifacts.

(a)

(c)

MRgRT.

The

acquired

spatial

resolution

was

(b)

(d)

F I G . 1 . Direct tumor visualization system
in 0.35 T MRgRT. (a) In‐room display
system with magnetic resonance (MR)‐
compatible projector and adjustable stand,
(b) Image display inside the bore of the
0.35 T MRgRT treatment system. (c)
Diagram of the video signal capturing,
processing, and presentation system. (d)
Example of the treatment delivery system
display including cine magnetic resonance
imaging and beam delivery information.
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2.B | Direct tumor visualization system in 0.35T
MRgRT

2.C | Clinical workﬂow of direct tumor visualization

The direct tumor visualization system in the 0.35 T MRgRT environ-

our adaptive radiotherapy workﬂow.15,19 The adaptive treatment plan-

ment is shown in Fig. 1. The direct tumor visualization system has

ning and delivery workﬂows have been discussed in previous

three components, including: (a) video signal capture from the TDS

reports.15,16 The additional workﬂow speciﬁc to providing direct

system; (b) video signal processing for visual guidance; and (c) in‐

tumor visualization to the patient is described below. Figure 2 pre-

room display.

sents an outline of the clinical workﬂow of the direct tumor visualiza-

Visual biofeedback based on direct tumor visualization was applied in

First, we set up dual screen output on the TDS system with

tion system, including: (a) introduction to patients; (b) patient setup; (c)

vendor's support such that the TDS display at the treatment con-

black screen for waiting; and (d) visual guidance during treatment.

sole is independent from our signal capturing device. An Epiphan

First, before the patient enters the vault, they received a short intro-

DVI2USB 3.0 screen grabber (Epiphan video, CA) was used in

duction using a prepared demonstration set of cine MRIs displayed in

resolution

the console area before the treatment started at the ﬁrst fraction. The

(1900 × 1200) display requirements of the TDS for physician

brief introduction included an overview of the MRIs, and descriptions

image viewing. The device was conﬁgured with the same resolu-

of the target and auto‐segmented contours, and the beam‐status indi-

place

of

a

video

splitter

to

meet

the

high

tion display extended display identiﬁcation data (EDID) before

cator displayed on the visual guidance. Orientative information about

connecting to the TDS system. Figure 1(c) shows how the frame

MRI images and abdominal anatomy was provided to patients since

grabber was connected between the TDS system and the visual

they may not have previously viewed human MRIs. Second, we pro-

guidance computer.

jected the demonstration cine MRIs inside the bore of the treatment

Second, Streamlabs open broadcast software (OBS), (Logitech

system while the patient was set up for treatment. The display location

International) was installed on the visual guidance computer to

was adjusted using an adjustable stand based on patient position

provide video signal capturing, processing, and presenting for

inside the bore. The size and focus of the image were adjusted based

visual guidance. Video signal processing using the software

on the patient’s preferences. Patient‐speciﬁc adjustments were

allowed personalization of the patient’s display. For example, we

required due to differences in patient eyesight, immobilization position

presented only 2D cine MRIs to the patient unlike previous stud-

and location in the bore. Third, we projected a black screen during the

ies that displayed the entire TDS display.17,18 In addition, visual

treatment setup 3D MRI and the adaptive radiotherapy preparation

guidance‐speciﬁc notiﬁcations were added, such as a real‐time

process. Displaying the black screen reduced patient discomfort

beam‐status indicator on the displayed images [Fig. 1(b)]. The pro-

caused by the bright display and hid extraneous information from the

cessed video signal was sent to the in‐room projector through an

patient that might confuse them or induce stress during the MRI and

optic ﬁber.

procedure preparation. Fourth, once beam delivery was ready to

A Hyperion MRI digital projection system (Psychology Software

begin, we provided the visual guidance display to patients. As shown

Tools, Inc, PA) was used to convert and present the signal in the

in Fig. 2, the visual guidance displayed only 2D cine MRIs with the tar-

treatment room as shown in Fig. 1(a). As Kim et al. suggested, we

get and auto‐segmented contours, and the beam‐status indicator. The

displayed the images inside the bore of the treatment system. Addi-

size and position of the displayed information, including the beam‐sta-

tionally, an adjustable stand was developed and used to adjust the

tus sign, were adjusted in real time while the patient was on the treat-

display location for patients and a projector keystone correction was

ment table, if needed. Patients treated without visual guidance

used to minimize image distortion due to oblique projection as

received the standard instructions to remain still and breathe normally

shown in Fig. 1(a).

throughout the treatment process and were given periodic reminders.

F I G . 2 . Clinical workﬂow of the direct
tumor visualization. (a) Workﬂow diagram
and corresponding example displays, and
(b) Corresponding scene options on the
live streaming software, Streamlabs open
broadcast software.
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2.D | Evaluation of tumor motion control and
delivery time
Cine MRIs acquired during each treatment fraction were analyzed to
evaluate tumor motion control with and without visual guidance.
After treatment, the TDS produced a three channel RGB video ﬁle
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ﬁrst fraction and two minutes for projector adjustment at each fraction.

3.B | Evaluation of tumor motion control and
Beam‐on time

of the cine acquisition including gating contour and tumor tracking

For the patients without visual guidance, the mean (±SD) of maxi-

contours overlaid on the patient anatomy. In‐house software was

mum tumor motion extent was 14.4 ± 11.2 mm (range, 2.2–

developed in MATLAB 2019b (MathWorks) to isolate the contours

48.2 mm). Patients with the visual guidance system in place had a

from the underlying grayscale image. Once tracking contours were

mean (± SD) maximum tumor motion extent of 13.0 ± 7.9 mm

extracted from each serial MRI, they were combined to produce a

(range, 3.3–27.8 mm). There was no signiﬁcant difference in maxi-

probability distribution of tumor position. Tumor motion beyond the

mum tumor motion extent between the two groups (P = 0.54).

gating contour boundary in the inferior direction was quantiﬁed

When the target tracking contour was outside the gating contour,

using superior‐inferior proﬁles. Only inferior motion was taken into

patients without visual guidance had an excursion of >1.9 mm for

consideration because the gating target placement within the bound-

50% of the imaging time and 2.0 mm for 50% of the imaging time

ary was at the full exhalation position, thus limiting superior excur-

with visual guidance in place. The target contour extended 3 mm

sion outside of the gating target. A signiﬁcant‐difference analysis

outside of the gating contour (mean ± SD) for 33.6 ± 24.9% of the

was performed using an unpaired t‐test. Tumor motion was evalu-

time without visual guidance, and 37.2 ± 26.4% of the time with

ated for seven patients without visual guidance, for a total of 40 full

visual guidance (P = 0.56). The patient treated both with and without

or partial fractions (143 713 cine frames), and six patients with visual

visual guidance showed a maximum tumor motion extent of 5.2 and

guidance, a total of 33 full or partial fractions (142 282 cine frames),

4.1 mm without and with visual guidance in place, and the tracking

including one patient treated both with and without visual guidance.

contour was outside of the gating contour 53% of the imaging time

This patient was treated with both methods due to changes in medi-

both with and without visual guidance. The average distribution of

cal condition over the course of their treatment. Patients treated

motion extent for patients with and without visual guidance is

without visual guidance included two males and ﬁve females (age 55

shown in Fig. 3. The distribution of the auto‐segmented target track-

to 71, average: 62.5), and patients treated with visual guidance

ing contour is shown in Fig. 4. The outlier motion, deﬁned as occur-

included three males and three females (age 53 to 71, average:

ring less than 25% of the cine MRI images, is shown in Fig. 5. The

61.7). The treatment locations without visual guidance include four

target tracking contour was completely inside the gating contour

pancreas, two liver, and one iliac. The treatment locations with visual

74.5% ± 22.5% and 79.6% ± 25.5% of the time for patients without

guidance include three pancreas, one liver, one iliac, and one lymph

and with visual guidance, respectively, when imaging was being per-

node. The extent of motion and probability distribution were calcu-

formed. There was no signiﬁcant difference in the percentage of

lated. The treatment duty cycle was calculated as the percentage of

frames the target tracking contour was completely inside the gating

frames which had the target contour entirely contained by the gating

contour (P = 0.63). Beam‐on time as a percentage had a mean (±SD)

contour. Beam‐on time was recorded as a percentage, by the treat-

of 43.9 ± 15.3% without visual guidance, and 48.0 ± 21.2% with

ment machine, from when the beam‐on button was engaged to the

visual guidance. There was no signiﬁcant difference in beam‐on time

end of radiation delivery, and included time required for gantry

as a percentage between the two groups (P = 0.34). The mean (±SD)

motion and when the beam was turned off for target gating (Beam‐

time from patient entry to exit of the treatment room was recorded

on‐time/Treatment delivery time × 100). Duty cycle was calculated

by the radiation therapist and was 64.5 ± 22.7 min without visual

separately from beam‐on time by excluding time when the gantry

guidance and 79.4 ± 14.8 min with visual guidance.

was in motion.

3 | RESULTS
3.A | Implementation of direct tumor visualization

4 | DISCUSSION
Direct tumor visualization for patient biofeedback in 0.35 T MRgRT
was developed and implemented in our clinic. Compared to previous

The direct tumor visualization system was successfully implemented

studies in MRgRT, the proposed system had multiple unique features

on a 0.35 T MRgRT system in our clinic. Implementation included

including: (a) video signal capturing, (b) visual guidance projection,

the system installation, training and instruction material preparation,

and (c) visual display layout.

workﬂow development, and staff training. System adjustment and

In this study, we used a frame grabber instead of a video signal

optimization, updates to materials, and refresher training were con-

splitter. Since the TDS system requires a high display resolution, the

ducted in a developing loop. Patient introduction to the system and

TDS control room display resolution must not be compromised by

projector adjustment required approximately seven minutes to per-

any secondary display device. A secondary monitor or a projector

form prior to treatment, including ﬁve minutes for education at the

might reduce the TDS display resolution, but the conﬁgured frame

KIM
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F I G . 3 . The percentage of cine magnetic
resonance imaging (MRI) frames that the
target tracking contour extends outside of
the gating contour by the indicated
distance shown as patient averages. The
average of all patients is shown as a black
line. (a) without visual guidance (nVG), and
(b) with visual guidance (VG). (c) presents
an average of all patients both without and
with visual guidance (VG). (d) and (e)
shows the target tracking contour motion
outside of the gating contour for all
individual fractions of a single patient
without and with visual guidance,
respectively. Both patients in (d) and (e)
were treated for pancreatic disease.

grabber does not. In addition, when a video signal splitter is powered

display including the beam‐status sign can be adjusted in real‐time,

off, neither output display receives a video signal because the video

patient‐speciﬁc adjustment can be applied. Additional display fea-

signal splitter produces both signals. In contrast, by using a frame

tures for visual guidance and remote plan review, via live streaming,

grabber the TDS display remains independent and its operation is

can be added using proper software, such as Streamlabs OBS.

unaffected by screen grabber status.17,18 This is important in pre-

Although not speciﬁcally assessed by this study, showing only perti-

venting treatment delays due to potential splitter malfunction or

nent treatment aspects to the patient, instead of all the information

troubleshooting.

including gantry angles and monitor units, may be important in

Video signal capturing by the frame grabber provided more

reducing patient anxiety from excessive information.

options in signal processing than using a video signal splitter. Once

A similar MRI‐compatible display was used in our study com-

the video signal is received by the visual guidance computer, addi-

pared to previous studies.18 Since we displayed the images inside

tional software can modify the acquired frames for generating cus-

the bore of the treatment system using a projector like Kim et al.,

tomizable displays that can be altered in real time to patient or

the resulting images were distorted due to the oblique projection, so

physician needs. For example, we used a live streaming freeware,

a keystone function of the projector was used to correct image dis-

Streamlabs OBS, to crop the original video signal to only display the

tortion. This approach is sufﬁcient to remove the projection screen

cine MRI instead of the entire TDS screen, as shown in Fig. 1. We

and adjustable mirror required for a conventional setup. In our

also added the beam‐status sign to assist patients in staying focused

approach, we developed an adjustable stand which can be used to

on motion control. Since the size and position of the main guidance

adjust the projection angle and display location for patients
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F I G . 4 . Distribution of auto‐segmented target contour from cine magnetic resonance imaging (MRI) without visual guidance (a), and with
visual guidance (b) for a single fraction of six patients for each group. Individual patients are indicated by nVG(#) for no visual guidance and
VG(#) with visual guidance in place. The color bar scale indicates the percent of frames that the region was encompassed by the auto‐
segmented target contour.

F I G . 5 . Distribution outliers from auto‐segmented target contour from cine magnetic resonance images (MRI) without visual guidance (a),
and with visual guidance in place (b) for a single fraction of six patients for each group. Individual patients are indicated by nVG(#) for no
visual guidance and VG(#) with visual guidance in place. The color bar scale indicates the percent of frames that the region was encompassed
by the auto‐segmented target contour.

compared to the approach of Kim et al. This system also does not

a black screen option for use during waiting periods to prevent

require any additional hardware to be placed on the patient, elimi-

displaying unnecessary information to the patient, including 3D

nating the possibility of broken components or additional cleaning

MR imaging and adaptive radiotherapy preparation procedures. In

precautions.

addition, it reduced patient discomfort from the bright background

Through this study, we investigated the implementation of the

display of the projector. However, the black screen period

visual guidance system in a clinical workﬂow. The workﬂow

between the setup and the visual guidance was long enough for

included a brief introduction to the visual guidance system for

patients to fall asleep so we informed the patients when the

patients. A demonstration video for the introduction and the

visual guidance started. Since cine MRIs were displayed on the

patient setup was prepared. The demonstration video was espe-

TDS monitor once the treatment started, we ran the visual guid-

cially helpful for educating patients who were unfamiliar with MRI,

ance session as the beam‐on button was pressed. It is noted that

anatomical images, and the visual guidance process. We included

because the cine MRI displayed on the TDS system during gantry

KIM
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motion is not updated, the visual guidance appeared frozen to the
patient.
Target tracking assessment of patients with and without the
visual guidance system in place showed that the duty cycle remained
similar. However, the target tracking contour was more likely to
extend a greater distance outside of the gating contour without
visual guidance. The target tracking contour had a greater range of
motion outside the gating contour and was more likely to be outside
of the target window, indicating that providing visual guidance has
the potential beneﬁt of reducing motion range. However, an additional study with randomized patient cohorts would be required to
determine the true beneﬁt. During treatment, patients were
observed to be more conscious of their breathing and attempting to
keep the displayed target contour within the gating contour, especially when the beam‐on indicator was active. Patients were not
instructed to alter their breathing during the training session but
changed their breathing pattern when presented with the beam‐on
indicator. The addition of training time to familiarize patients with
the system may reduce any total time beneﬁt of the system, however time spent outside of the MRI bore is more desirable than
treatment time in the bore where the patient may experience discomfort due to treatment positioning. It is noted that this study did
not consider number of treatment beams, beam segments, monitor
units, or setup difﬁculty, which could all have a signiﬁcant impact on
the total time spent in the treatment room by the patient. In the
future, we will conduct additional studies to assess the time impact
in further detail.

5 | CONCLUSION
We demonstrated the clinical feasibility of direct tumor visualization
to patients in MRgRT. It allows tumor motion control in free breathing, with the potential to reduce on‐table treatment time and tumor
motion range. Clinical workﬂow for the proposed system can be
easily adapted for any type of MRgRT.
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